|
Symbol Name ID |
Plau
plasminogen activator, urokinase MGI:97611 |
| * | Aspects of the system are reported to show a normal phenotype. |
| Darker colors indicate more annotations |
| Human Phenotypes | Decreased circulating GABA concentration |
| Disease(s) Associated with PLAU | |
| Alzheimer's disease 1 |
| Mouse Phenotypes | homeostasis/metabolism phenotype |
abnormal circulating protein level |
abnormal circulating alanine transaminase level |
increased circulating alanine transaminase level |
reduced thrombolysis |
abnormal thrombosis |
increased susceptibility to induced thrombosis |
subcutaneous edema |
decreased liver glycogen level |
increased liver cholesterol level |
increased liver free fatty acids level |
increased liver triglyceride level |
abnormal acute phase protein level |
abnormal cytokine level |
decreased physiological sensitivity to xenobiotic |
abnormal response to injury |
|
| Availability | Mouse Genotype | ||||||||||||||||
| Plautm1.1Bug/Plautm1.1Bug | * | ||||||||||||||||
| Plautm1Mlg/Plautm1Mlg | |||||||||||||||||
| Tg(Mup3-Plau)350-2Eps/0 | |||||||||||||||||
| Tg(Mup3-Plau)350-2Eps/? | |||||||||||||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 05/14/2024 MGI 6.23 |
|
|
|
||
Analysis Tools